Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Late onset dysthyroid optic neuropathy

P I Chou1, S E Feldon

  • 1Doheny Eye Institute, University of Southern California School of Medicine, Los Angeles.

Thyroid : Official Journal of the American Thyroid Association
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.

Experimental eye research·2011
Same author

Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

PPAR research·2010
Same author

Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.

PPAR research·2008
Same author

The relation of Graves' ophthalmopathy to circulating thyroid hormone status.

The British journal of ophthalmology·2003
Same author

Adrenergic supersensitivity of rabbit choroidal blood vessels after sympathetic denervation.

Current eye research·2002
Same author

The use of autologous fibrinogen concentrate in treating ocular hypotony after glaucoma filtration surgery.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2002

Rare cases of late-onset dysthyroid optic neuropathy occurred years after stable Graves' ophthalmopathy. Vision improved with corticosteroids or surgery, suggesting mechanical vascular factors in optic nerve decompensation.

Area of Science:

  • Ophthalmology
  • Endocrinology

Background:

  • Dysthyroid optic neuropathy (DON) is a rare complication of Graves' ophthalmopathy.
  • It typically occurs during active phases of thyroid eye disease.

Observation:

  • Three middle-aged patients presented with rare late-onset DON.
  • Optic neuropathy developed 7-12 years after their Graves' ophthalmopathy stabilized.
  • No signs of orbital inflammation reactivation were present.

Findings:

  • Vision loss in these cases responded to corticosteroid treatment or surgical decompression.
  • Patients had no concurrent diabetes, hypertension, or cardiovascular disease.
  • This presentation is atypical for standard DON.

Implications:

Related Experiment Videos

  • The findings suggest that mechanical vascular factors may cause optic nerve decompensation in stable Graves' ophthalmopathy.
  • This highlights the need to consider non-inflammatory mechanisms in late-onset DON.
  • Further research into vascular etiologies of DON is warranted.